Comparison of Alectinib/Crizotinib Data in First-Line Therapy in Patients with Anaplastic Lymphomakinase- Positive Nonsmall Cell Lung Carcinoma with Poor Prognostic Features for Alectinib için istatistikler
Toplam ziyaret
views | |
---|---|
Comparison of Alectinib/Crizotinib Data in First-Line Therapy in Patients with Anaplastic Lymphomakinase- Positive Nonsmall Cell Lung Carcinoma with Poor Prognostic Features for Alectinib | 1 |
Aylık toplam ziyaret
views | |
---|---|
Ocak 2025 | 0 |
Şubat 2025 | 0 |
Mart 2025 | 0 |
Nisan 2025 | 0 |
Mayıs 2025 | 0 |
Haziran 2025 | 0 |
Temmuz 2025 | 0 |
Dosya Ziyaretleri
views | |
---|---|
1502.pdf | 11 |